Strategic Acquisition Microptic was acquired by Hamilton Thorne in December 2022, signaling a potential alignment with laser-based fertility and SCA technology portfolios. This creates a cross-sell opportunity for complementary equipment, service contracts, and integrated workflows with laser systems and diagnostic platforms.

Global Collaboration The company hosts initiatives like the Global Andrology Forum and Masterclasses, indicating active engagement with international researchers and clinicians. Leverage these networks to propose bundled training, implementation services, and premium support for labs expanding semen analysis capabilities.

SCA Leadership Sperm Class Analyzer systems are a core, scalable product line with multiple configurations for human, animal, research, and toxicology. Target high-volume fertility clinics, animal production facilities, and research centers with needs for standardized, AI-driven semen analysis and cytogenetics solutions.

ISO Certified Quality With 9001 and 13485 certifications, Microptic emphasizes quality management and medical device standards. Market opportunities exist for refurbished or upgradeable systems, extended warranties, and compliance-heavy deployments in regulated markets.

SMB Growth Potential Current revenue is under $1M with a small employee base, suggesting appetite for scalable, repeatable sales models, such as subscription-based service plans, bundled consumables, and regional channel partnerships to accelerate geographic expansion.